| 臺大學術典藏 |
2021-03-18T02:03:17Z |
Typhlitis associated with Candida albicans and Pseudomonas aeruginosa infection in a patient with herbal drug-induced neutropenia [2]
|
Liou J.-M.;Lin J.-T.;Wu M.-S.;Cheng T.-Y.;Chia-Tung Shun;Wang H.-P.; Liou J.-M.; Lin J.-T.; Wu M.-S.; Cheng T.-Y.; CHIA-TUNG SHUN; Wang H.-P. |
| 臺大學術典藏 |
2021-03-18T02:03:07Z |
Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer
|
Liou J.-M.;Wu M.-S.;Lin J.-T.;Wang H.-P.;Huang S.-P.;Chiu H.-M.;Lee Y.-C.;Lin Y.-B.;Chia-Tung Shun;Liang J.-T.; Liou J.-M.; Wu M.-S.; Lin J.-T.; Wang H.-P.; Huang S.-P.; Chiu H.-M.; Lee Y.-C.; Lin Y.-B.; CHIA-TUNG SHUN; Liang J.-T. |
| 臺大學術典藏 |
2021-03-18T02:03:07Z |
IL-1B-511 C→T polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese
|
Liou J.-M.; Lin J.-T.; Wang H.-P.; Huang S.-P.; Lee Y.-C.; Chiu H.-M.; CHIA-TUNG SHUN; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:07Z |
Screening for colorectal cancer in average-risk Chinese population using a mixed strategy with sigmoidoscopy and colonoscopy
|
Liou J.-M.; Lin J.-T.; Huang S.-P.; Chiu H.-M.; Wang H.-P.; Lee Y.-C.; Lin J.-W.; CHIA-TUNG SHUN; Liang J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:03Z |
RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women
|
Liou J.-M.; Lin J.-T.; Huang S.-P.; Wu C.-Y.; Wang H.-P.; Lee Y.-C.; Chiu H.-M.; CHIA-TUNG SHUN; Lin M.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:57Z |
Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer
|
Liou J.-M.;Chia-Tung Shun;Liang J.-T.;Chiu H.-M.;Chen M.-J.;Chen C.-C.;Wang H.-P.;Wu M.-S.;Lin J.-T.; Liou J.-M.; CHIA-TUNG SHUN; Liang J.-T.; Chiu H.-M.; Chen M.-J.; Chen C.-C.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-18T02:02:53Z |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
|
Liou J.-M.;Wu M.-S.;Chia-Tung Shun;Chiu H.-M.;Chen M.-J.;Chen C.-C.;Wang H.-P.;Lin J.-T.;Liang J.-T.; Liou J.-M.; Wu M.-S.; CHIA-TUNG SHUN; Chiu H.-M.; Chen M.-J.; Chen C.-C.; Wang H.-P.; Lin J.-T.; Liang J.-T. |
| 臺大學術典藏 |
2021-03-18T02:02:50Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.;Chen C.-C.;Chang C.-Y.;Chen M.-J.;Fang Y.-J.;Lee J.-Y.;Chen C.-C.;Hsu S.-J.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Chang L.;Chang W.-H.;Wang H.-P.;Chia-Tung Shun;Wu J.-Y.;Lee Y.-C.;Lin J.-T.;Wu M.-S.;Lin C.-H.;Chow L.-P.;Cheng T.-Y.;Wu C.-Y.;Lee Ching-Tai C.-T, Wang W.-L.;Tai C.-M.;Wang Y.-C.;Wang C.-H.;Kuo S.-H.;Wu C.-Y.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; CHIA-TUNG SHUN; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-18T02:02:50Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.;Chen C.-C.;Chen M.-J.;Chen C.-C.;Chang C.-Y.;Fang Y.-J.;Lee J.-Y.;Hsu S.-J.;Luo J.-C.;Chang W.-H.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Wang H.-P.;Yang U.-C.;Chia-Tung Shun;Lin J.-T.;Lee Y.-C.;Wu M.-S.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; CHIA-TUNG SHUN; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:44Z |
Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer
|
Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; CHIA-TUNG SHUN; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; Liang J.-T. |
| 臺大學術典藏 |
2021-03-18T02:02:40Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:35Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-18T02:02:34Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-18T02:02:32Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.;Liou J.-M.;Chen M.-J.;Chen C.-C.;Kuo S.-H.;Lai I.-R.;Yeh K.-H.;Lin M.-T.;Wang H.-P.;Cheng A.-L.;Lin J.-T.;Chia-Tung Shun;Wu M.-S.; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; CHIA-TUNG SHUN; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:32Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.;Chen L.-T.;Lin C.-W.;Yeh K.-H.;Chia-Tung Shun;Tzeng Y.-S.;Liou J.-M.;Wu M.-S.;Hsu P.-N.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; CHIA-TUNG SHUN; Tzeng Y.-S.; Liou J.-M.; Wu M.-S.; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-18T02:02:26Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.;Chen C.-C.;Fang Y.-J.;Chen P.-Y.;Chang C.-Y.;Chou C.-K.;Chen M.-J.;Tseng C.-H.;Lee J.-Y.;Yang T.-H.;Chiu M.-C.;Yu J.-J.;Kuo C.-C.;Luo J.-C.;Hsu W.-F.;Hu W.-H.;Tsai M.-H.;Lin J.-T.;Chia-Tung Shun;Twu G.;Lee Y.-C.;Bair M.-J.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-18T02:02:25Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.;Chen P.-Y.;Luo J.-C.;Lee J.-Y.;Chen C.-C.;Fang Y.-J.;Yang T.-H.;Chang C.-Y.;Bair M.-J.;Chen M.-J.;Hsu Y.-C.;Hsu W.-F.;Chang C.-C.;Lin J.-T.;Chia-Tung Shun;El-Omar E.M.;Wu M.-S.;Liou J.-M.;Lee Y.-C.;Lin J.-T.;Wu C.-Y.;Wu J.-Y.;Chen C.-C.;Lin C.-H.;Fang Y.-R.;Bair M.-J.;Luo J.-C.;Cheng T.-Y.;Tseng P.-H.;Chiu H.-M.;Chang C.-C.;Yu C.-C.;Chiu M.-C.;Chen Y.-N.;Hu W.-H.;Chou C.-K.;Tai C.-M.;Lee C.-T.;Wang W.-L.;Chang W.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; CHIA-TUNG SHUN; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-18T02:02:18Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.;Tai J.J.;Chen L.-T.;Wu M.-S.;Yeh K.-H.;Lin C.-W.;Wang T.-E.;Wang H.-P.;Yu F.-J.;Liou J.-M.;Hsiao C.-F.;Cheng T.-Y.;Yeh H.-J.;Ko C.-W.;Chen M.-J.;Lo G.-H.;Hsu P.-I.;Chang C.-S.;Hwang W.-S.;Chuang S.-S.;Lee H.-W.;Chia-Tung Shun;Chiu C.-F.;Wang W.-M.;Hsieh C.-Y.;Liu T.-W.;Lin J.-T.;Kuo S.-H.;Cheng A.-L.; Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-10T07:09:18Z |
Gastrointestinal: Burkitt's lymphoma
|
Liou J.-M.;Wang H.-P.;Ko B.-S.;Tsu-Yao Cheng;Wu M.-S.;Lin J.-T.; Liou J.-M.; Wang H.-P.; Ko B.-S.; TSU-YAO CHENG; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-10T07:09:17Z |
Typhlitis associated with Candida albicans and Pseudomonas aeruginosa infection in a patient with herbal drug-induced neutropenia [2]
|
Liou J.-M.;Lin J.-T.;Wu M.-S.;Tsu-Yao Cheng;Shun C.-T.;Wang H.-P.; Liou J.-M.; Lin J.-T.; Wu M.-S.; TSU-YAO CHENG; Shun C.-T.; Wang H.-P. |
| 臺大學術典藏 |
2021-03-10T07:09:15Z |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: A randomised comparative trial with crossover design
|
Liou J.-M.;Lin J.-T.;Chang C.-Y.;Chen M.-J.;Tsu-Yao Cheng;Lee Y.-C.;Chen C.-C.;Sheng W.-H.;Wang H.-P.;Wu M.-S.; Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; TSU-YAO CHENG; Lee Y.-C.; Chen C.-C.; Sheng W.-H.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-10T07:09:13Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; TSU-YAO CHENG; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-10T07:09:08Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.;Chen P.-Y.;Luo J.-C.;Lee J.-Y.;Chen C.-C.;Fang Y.-J.;Yang T.-H.;Chang C.-Y.;Bair M.-J.;Chen M.-J.;Hsu Y.-C.;Hsu W.-F.;Chang C.-C.;Lin J.-T.;Shun C.-T.;El-Omar E.M.;Wu M.-S.;Liou J.-M.;Lee Y.-C.;Lin J.-T.;Wu C.-Y.;Wu J.-Y.;Chen C.-C.;Lin C.-H.;Fang Y.-R.;Bair M.-J.;Luo J.-C.;Tsu-Yao Cheng;Tseng P.-H.;Chiu H.-M.;Chang C.-C.;Yu C.-C.;Chiu M.-C.;Chen Y.-N.;Hu W.-H.;Chou C.-K.;Tai C.-M.;Lee C.-T.;Wang W.-L.;Chang W.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; TSU-YAO CHENG; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-10T07:09:07Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; TSU-YAO CHENG; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T01:47:47Z |
The passage of a colonic cast
|
TUNG-HUNG SU; Liou J.-M.; Wang H.-P. |
| 臺大學術典藏 |
2021-03-09T01:43:22Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-08T08:06:07Z |
Endoscopic submucosal dissection comparing with surgical resection in patients with early gastric cancer – A single center experience in Taiwan
|
Hong T.-C.;Liou J.-M.;Yeh C.-C.;Yen H.-H.;Wu M.-S.;I-Rue Lai;Chen C.-C.; Hong T.-C.; Liou J.-M.; Yeh C.-C.; Yen H.-H.; Wu M.-S.; I-RUE LAI; Chen C.-C. |
| 臺大學術典藏 |
2021-03-05T09:38:15Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; CHUNG-WU LIN; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-05T08:19:40Z |
Emergency endoscopy for upper gastrointestinal bleeding in patients with coronary artery disease
|
PING-HUEI TSENG; Liou J.-M.; Lee Y.-C.; Lin L.-Y.; Yan-Zhen Liu A.; Chang D.-C.; Chiu H.-M.; Wu M.-S.; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2021-03-05T08:19:38Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; PING-HUEI TSENG; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-05T08:19:37Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-03-05T08:19:37Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:34Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; PING-HUEI TSENG; Chen C.-C.; Chen M.-J.; Liou J.-M.; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; Wang H.-P.; Chiang H.; Lin J.-T.; Chen H.-H.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:33Z |
Performance of a one-step fecal sample-based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings
|
Lee Y.-C.; PING-HUEI TSENG; Liou J.-M.; Chen M.-J.; Chen C.-C.; Tu C.-H.; Chiang T.-H.; Chiu H.-M.; Lai C.-F.; Ho J.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:30Z |
Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease
|
PING-HUEI TSENG; Yang W.-S.; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:30Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; PING-HUEI TSENG; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-05T08:19:25Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; PING-HUEI TSENG; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-05T06:07:33Z |
Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease
|
Liou J.-M.; Chen C.-Y.; Wu M.-S.; Hsu M.-T.; Fang C.-C.; Lin Y.-G.; MING-CHU CHANG; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2021-02-26T02:00:08Z |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: A randomised comparative trial with crossover design
|
Liou J.-M.;Lin J.-T.;Chang C.-Y.;Chen M.-J.;Cheng T.-Y.;Lee Y.-C.;Chen C.-C.;Wang-Huei Sheng;Wang H.-P.;Wu M.-S.; Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; Cheng T.-Y.; Lee Y.-C.; Chen C.-C.; WANG-HUEI SHENG; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2021-02-26T02:00:05Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Liou J.-M.; Chang C.-Y.; WANG-HUEI SHENG; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-26T02:00:03Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; WANG-HUEI SHENG; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-26T01:59:43Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Cheng A.;Wang-Huei Sheng;Liou J.-M.;Wang H.-P.;Wu M.-S.;Lin J.-T.;Chang S.-C.; Cheng A.; WANG-HUEI SHENG; Liou J.-M.; Wang H.-P.; Wu M.-S.; Lin J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-23T08:26:25Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Sung-Hsin Kuo;Yeh K.-H.;Chen L.-T.;Lin C.-W.;Hsu P.-N.;Wu M.-S.;Liou J.-M.;Tsai H.-J.;Tzeng Y.-S.;Cheng A.-L.; SUNG-HSIN KUO; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Wu M.-S.; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:18Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.;Liou J.-M.;Chen M.-J.;Chen C.-C.;Sung-Hsin Kuo;Lai I.-R.;Yeh K.-H.;Lin M.-T.;Wang H.-P.;Cheng A.-L.;Lin J.-T.;Shun C.-T.;Wu M.-S.; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; SUNG-HSIN KUO; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:18Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Sung-Hsin Kuo;Chen L.-T.;Lin C.-W.;Yeh K.-H.;Shun C.-T.;Tzeng Y.-S.;Liou J.-M.;Wu M.-S.;Hsu P.-N.;Cheng A.-L.; SUNG-HSIN KUO; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; Wu M.-S.; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:17Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Sung-Hsin Kuo;Yeh K.-H.;Wu M.-S.;Lin C.-W.;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; SUNG-HSIN KUO; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:10Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.;Tai J.J.;Chen L.-T.;Wu M.-S.;Yeh K.-H.;Lin C.-W.;Wang T.-E.;Wang H.-P.;Yu F.-J.;Liou J.-M.;Hsiao C.-F.;Cheng T.-Y.;Yeh H.-J.;Ko C.-W.;Chen M.-J.;Lo G.-H.;Hsu P.-I.;Chang C.-S.;Hwang W.-S.;Chuang S.-S.;Lee H.-W.;Shun C.-T.;Chiu C.-F.;Wang W.-M.;Hsieh C.-Y.;Liu T.-W.;Lin J.-T.;Sung-Hsin Kuo;Cheng A.-L.; Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; SUNG-HSIN KUO; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-18T08:38:13Z |
Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer
|
Liou J.-M.; Shun C.-T.; Liang J.-T.; Chiu H.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-18T08:38:13Z |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: A randomised comparative trial with crossover design
|
Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; Cheng T.-Y.; Lee Y.-C.; CHIEN-CHUAN CHEN; Sheng W.-H.; Wang H.-P.; Wu M.-S. |
